Why Choose EverydayMeds for Your Weight Management Prescription?
Understanding the Key Difference Between Mounjaro and Wegovy for Online Prescriptions
The fundamental difference between Mounjaro and Wegovy lies in their active ingredients and mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, whilst Mounjaro uses tirzepatide, which targets both GIP and GLP-1 receptors in a dual-action approach. Both prescription-only medicines require clinical assessment through our online platform, where licensed UK prescribers evaluate your medical history, BMI, and any contraindications. Our streamlined process means you can access either treatment without the traditional barriers of GP referrals or lengthy waiting times.
When comparing the difference between Mounjaro and Wegovy through online prescription services, storage requirements also vary significantly. Wegovy offers superior travel convenience with up to 6 weeks at room temperature once removed from the fridge, compared to Mounjaro's 21-day limit. This practical advantage makes Wegovy particularly suitable for frequent travellers or those with inconsistent fridge access. Both medications follow similar dose escalation protocols over 16-20 weeks, reaching their respective maintenance doses with careful monitoring through our clinical team.
Pricing Comparison: Mounjaro vs Wegovy Online Prescription Costs
Understanding the cost difference between Mounjaro and Wegovy helps inform your prescription choice at EverydayMeds. Wegovy single pens range from £79.99 for the 0.25mg starter dose (with FIRST40 discount applied) up to £209.99 for the 2.4mg maintenance dose. Our convenient bundle options include the Intro Duo (0.25mg & 0.5mg pens) for £169.99, providing your first 8 weeks of treatment in one order. Returning customers benefit from the DOSE25 discount code, whilst new patients automatically receive FIRST40 savings at checkout.
The price difference between Mounjaro and Wegovy reflects their different manufacturing processes and licensing pathways, though both represent significant investment in your long-term health journey. Our bundle pricing strategy focuses on convenience rather than savings—for example, the Ultimate Stability Trio provides three months of 2.4mg Wegovy maintenance supply for £649.99, ensuring consistent treatment without multiple orders. Both treatments require the same level of clinical oversight and cold-chain delivery, with identical prescription fees applied regardless of your chosen medication.
Clinical Evidence: How Mounjaro and Wegovy Compare in Weight Management Studies
The clinical difference between Mounjaro and Wegovy emerges from separate trial programmes with different study populations and endpoints. Wegovy's evidence base includes the comprehensive STEP trial series, with STEP 1 showing patients achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo, as reported by Wilding et al. in NEJM, 2021. The recent SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events amongst patients taking Wegovy alongside standard care.
Mounjaro's clinical programme focuses on its dual-agonist mechanism, though direct comparison of trial results between these medications isn't appropriate due to different study designs and participant characteristics. Both treatments require prescription-only access and must be used alongside a reduced-calorie diet and increased physical activity to achieve optimal outcomes. Your EverydayMeds prescriber can discuss which evidence base is most relevant to your individual health profile during the online assessment process.
How Wegovy Works: The Science Behind GLP-1 Weight Management
Wegovy functions as a GLP-1 receptor agonist, mimicking the action of glucagon-like peptide-1, a natural hormone your body produces in response to food intake. This mechanism helps reduce appetite by sending satiety signals to your brain's appetite control centres, promoting feelings of fullness after smaller meals. The medication may also slow gastric emptying, meaning food stays in your stomach longer, contributing to prolonged satisfaction between meals. Clinical studies suggest Wegovy can reduce food cravings and help patients develop healthier eating patterns when combined with appropriate lifestyle interventions. Unlike appetite suppressants that work through stimulant pathways, Wegovy's hormone-based approach offers a more physiological method of appetite regulation. This sophisticated mechanism requires careful dose escalation over 16 weeks to minimise side effects whilst maximising therapeutic benefits.
Your Online Prescription Journey: From Assessment to Delivery
The difference between Mounjaro and Wegovy prescription processes at EverydayMeds remains identical—both require our comprehensive 3-minute clinical assessment covering your medical history, current medications, BMI calculations, and weight management goals. Our licensed UK prescribers review every application within 3 working days (express 24-hour service available), ensuring thorough evaluation regardless of which treatment you're considering. Once approved, both medications undergo identical cold-chain packaging and next-day delivery protocols, maintaining the 2-8°C temperature requirements essential for medication stability. Your prescription includes detailed injection guidance, dose escalation schedules, and direct access to our clinical support team throughout your treatment journey. No GP appointment or specialist referral is required, making professional weight management support accessible from your home.
Storage and Practical Considerations for Both Treatments
The practical difference between Mounjaro and Wegovy becomes apparent in their storage flexibility and real-world usage requirements. Both medications require refrigerated storage at 2-8°C before first use, but Wegovy's superior room temperature stability (6 weeks vs Mounjaro's 21 days) provides significant lifestyle advantages. Each treatment uses pre-filled injection pens with needle safety features, though the specific pen designs differ between manufacturers. Wegovy's FlexTouch pen system includes dose confirmation windows and injection completion indicators, whilst maintaining the same once-weekly injection schedule as Mounjaro. Both require gradual dose escalation—Wegovy over 16 weeks to reach 2.4mg maintenance, following MHRA-approved protocols that cannot be accelerated regardless of patient preference. Your EverydayMeds delivery includes temperature monitoring stickers to ensure medication integrity throughout the supply chain.
Choosing Between Mounjaro and Wegovy: Prescriber-Led Decision Making
The choice difference between Mounjaro and Wegovy often depends on individual patient factors that our prescribers evaluate during your online consultation. Factors such as previous GLP-1 experience, specific health conditions, lifestyle requirements, and storage capabilities all influence treatment selection. Your prescriber may recommend starting with one medication based on your medical history, with the option to switch if initial response isn't optimal. Both medications are available through our platform, ensuring continuity of care regardless of which treatment proves most suitable for your circumstances.
The prescriber-patient discussion about Mounjaro vs Wegovy differences extends beyond mechanism of action to practical considerations like injection frequency, side effect profiles, and long-term treatment goals. Our clinical team maintains detailed records of your progress, enabling informed decisions about treatment adjustments or changes. Both Wegovy and Mounjaro are available from EverydayMeds—your prescriber can help determine which is right for you based on comprehensive assessment of your individual needs and medical suitability.
Start Your Weight Management Journey Today
Understanding the difference between Mounjaro and Wegovy empowers you to make informed decisions about your weight management journey with professional prescriber guidance. New patients can begin with our FIRST40 discount code, whilst returning customers benefit from DOSE25 savings, both applied automatically at checkout. Our GPhC-registered pharmacy (#9012878) ensures both treatments meet identical quality standards with full MHRA compliance and temperature-controlled delivery nationwide. The 3-minute online assessment opens access to either medication, with licensed prescriber review ensuring you receive the most appropriate treatment for your individual circumstances. Visit https://everydaymeds.co.uk/collections/wegovy to begin your confidential clinical assessment and take the first step towards professional weight management support.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
